HEADER HYDROLASE INHIBITOR 02-JUN-04 1TIJ TITLE 3D DOMAIN-SWAPPED HUMAN CYSTATIN C WITH AMYLOID-LIKE INTERMOLECULAR TITLE 2 BETA-SHEETS COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYSTATIN C; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: GAMMA-TRACE, POST-GAMMA-GLOBULIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CST3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: MC1061; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PHD 313 KEYWDS HUMAN CYSTATIN C DIMER, 3D DOMAIN SWAPPING, AMYLOID FORMATION, KEYWDS 2 INHIBITOR OF C1 AND C13 CYSTEINE PROTEASES, AMYLOID ANGIOPATHY, KEYWDS 3 CEREBRAL HEMORRHAGE, HYDROLASE INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR R.JANOWSKI,M.KOZAK,M.ABRAHAMSON,A.GRUBB,M.JASKOLSKI REVDAT 5 23-AUG-23 1TIJ 1 REMARK REVDAT 4 24-FEB-09 1TIJ 1 VERSN REVDAT 3 14-MAR-06 1TIJ 1 JRNL REVDAT 2 18-OCT-05 1TIJ 1 JRNL REVDAT 1 19-JUL-05 1TIJ 0 JRNL AUTH R.JANOWSKI,M.KOZAK,M.ABRAHAMSON,A.GRUBB,M.JASKOLSKI JRNL TITL 3D DOMAIN-SWAPPED HUMAN CYSTATIN C WITH AMYLOIDLIKE JRNL TITL 2 INTERMOLECULAR BETA-SHEETS. JRNL REF PROTEINS V. 61 570 2005 JRNL REFN ISSN 0887-3585 JRNL PMID 16170782 JRNL DOI 10.1002/PROT.20633 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH R.JANOWSKI,M.KOZAK,E.JANKOWSKA,Z.GRZONKA,A.GRUBB, REMARK 1 AUTH 2 M.ABRAHAMSON,M.JASKOLSKI REMARK 1 TITL HUMAN CYSTATIN C, AN AMYLOIDOGENIC PROTEIN, DIMERIZES REMARK 1 TITL 2 THROUGH THREE-DIMENSIONAL DOMAIN SWAPPING REMARK 1 REF NAT.STRUCT.BIOL. V. 8 316 2001 REMARK 1 REFN ISSN 1072-8368 REMARK 1 DOI 10.1038/86188 REMARK 1 REFERENCE 2 REMARK 1 AUTH R.JANOWSKI,M.ABRAHAMSON,A.GRUBB,M.JASKOLSKI REMARK 1 TITL 3D DOMAIN SWAPPING IN N-TRUNCATED HUMAN CYSTATIN C REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 1 REFERENCE 3 REMARK 1 AUTH M.KOZAK,E.JANKOWSKA,R.JANOWSKI,Z.GRZONKA,A.GRUBB, REMARK 1 AUTH 2 M.ALVAREZ FERNANDEZ,M.ABRAHAMSON,M.JASKOLSKI REMARK 1 TITL EXPRESSION OF SELENOMETHIONYL DERIVATIVE AND PRELIMINARY REMARK 1 TITL 2 CRYSTALLOGRAPHIC STUDIES OF HUMAN CYSTATIN C REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 55 1939 1999 REMARK 1 REFN ISSN 0907-4449 REMARK 1 DOI 10.1107/S090744499901121X REMARK 1 REFERENCE 4 REMARK 1 AUTH I.EKIEL,M.ABRAHAMSON,D.B.FULTON,P.LINDAHL,A.C.STORER, REMARK 1 AUTH 2 W.LEVADOUX,M.LAFRANCE,S.LABELLE,Y.POMERLEAU,D.GROLEAU, REMARK 1 AUTH 3 L.LESAUTER,K.GEHRING REMARK 1 TITL NMR STRUCTURAL STUDIES OF HUMAN CYSTATIN C DIMERS AND REMARK 1 TITL 2 MONOMERS REMARK 1 REF J.MOL.BIOL. V. 271 266 1997 REMARK 1 REFN ISSN 0022-2836 REMARK 1 DOI 10.1006/JMBI.1997.1150 REMARK 2 REMARK 2 RESOLUTION. 3.03 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.9 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.03 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 77294.260 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.2 REMARK 3 NUMBER OF REFLECTIONS : 11902 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1070 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.03 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.22 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1754 REMARK 3 BIN R VALUE (WORKING SET) : 0.3100 REMARK 3 BIN FREE R VALUE : 0.3470 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 8.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 157 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.028 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1776 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 22 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 57.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.32000 REMARK 3 B22 (A**2) : 4.32000 REMARK 3 B33 (A**2) : -8.65000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM SIGMAA (A) : 0.54 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.41 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.62 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.016 REMARK 3 BOND ANGLES (DEGREES) : 2.000 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.200 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.27 REMARK 3 BSOL : 26.97 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT CORRECTION USED REMARK 4 REMARK 4 1TIJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-JUN-04. REMARK 100 THE DEPOSITION ID IS D_1000022663. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-DEC-96 REMARK 200 TEMPERATURE (KELVIN) : 120 REMARK 200 PH : 4.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : BW7A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8885 REMARK 200 MONOCHROMATOR : SI 111 REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12273 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.030 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 7.400 REMARK 200 R MERGE (I) : 0.12300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.03 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.08 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.7 REMARK 200 DATA REDUNDANCY IN SHELL : 5.40 REMARK 200 R MERGE FOR SHELL (I) : 0.40900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: ONE HALF OF HUMAN CYSTATIN C CRYSTALLOGRAPHIC REMARK 200 DIMER WITH SWAPPED DOMAINS (PDB ENTRY 1G96) REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 77.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 5.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM SODIUM ACETATE, 20MM CACL2, 40 REMARK 280 -45% MPD, PH 4.8, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 72.22500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 45.74500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 45.74500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 36.11250 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 45.74500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 45.74500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 108.33750 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 45.74500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 45.74500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 36.11250 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 45.74500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 45.74500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 108.33750 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 72.22500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAINS INTERTWINED TO FORM A REMARK 300 3D DOMAIN SWAPPED DIMER. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6190 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13360 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -39.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1 REMARK 465 SER A 2 REMARK 465 PRO A 3 REMARK 465 GLY A 4 REMARK 465 LYS A 5 REMARK 465 PRO A 6 REMARK 465 SER B 1 REMARK 465 SER B 2 REMARK 465 PRO B 3 REMARK 465 GLY B 4 REMARK 465 LYS B 5 REMARK 465 PRO B 6 REMARK 465 PRO B 7 REMARK 465 ARG B 8 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO B 89 C - N - CA ANGL. DEV. = 9.7 DEGREES REMARK 500 PRO B 105 C - N - CA ANGL. DEV. = 9.8 DEGREES REMARK 500 CYS B 117 CA - CB - SG ANGL. DEV. = 9.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 40 141.38 168.65 REMARK 500 PRO A 89 -55.56 -29.70 REMARK 500 ALA A 95 136.03 -171.41 REMARK 500 LYS A 114 160.68 179.21 REMARK 500 GLN B 48 132.54 -171.69 REMARK 500 THR B 71 -163.80 -103.89 REMARK 500 ASN B 79 80.71 -65.78 REMARK 500 LEU B 80 35.90 -97.51 REMARK 500 ASP B 81 -70.93 -59.82 REMARK 500 ASP B 87 -82.97 -80.40 REMARK 500 PRO B 89 -14.58 -34.25 REMARK 500 VAL B 104 75.11 -156.03 REMARK 500 PRO B 105 -82.20 -18.84 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1G96 RELATED DB: PDB REMARK 900 HUMAN CYSTATIN C; DIMERIC FORM WITH 3D DOMAIN SWAPPING REMARK 900 RELATED ID: 1R4C RELATED DB: PDB REMARK 900 N-TRUNCATED HUMAN CYSTATIN C; DIMERIC FORM WITH 3D DOMAIN SWAPPING REMARK 900 RELATED ID: 1CEW RELATED DB: PDB REMARK 900 N-TERMINALLY TRUNCATED CHICKEN CYSTATIN REMARK 900 RELATED ID: 1STF RELATED DB: PDB REMARK 900 STEFIN B IN COMPLEX WITH PAPAIN REMARK 900 RELATED ID: 1RN7 RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN CYSTATIN D REMARK 900 RELATED ID: 1A67 RELATED DB: PDB REMARK 900 NMR STRUCTURE OF CHICKEN CYSTATIN REMARK 900 RELATED ID: 1DVC RELATED DB: PDB REMARK 900 NMR STRUCTURE OF STEFIN A REMARK 900 RELATED ID: 1N9J RELATED DB: PDB REMARK 900 NMR STRUCTURE OF 3D DOMAIN SWAPPED DIMER OF STEFIN A DBREF 1TIJ A 1 120 UNP P01034 CYTC_HUMAN 27 146 DBREF 1TIJ B 1 120 UNP P01034 CYTC_HUMAN 27 146 SEQRES 1 A 120 SER SER PRO GLY LYS PRO PRO ARG LEU VAL GLY GLY PRO SEQRES 2 A 120 MET ASP ALA SER VAL GLU GLU GLU GLY VAL ARG ARG ALA SEQRES 3 A 120 LEU ASP PHE ALA VAL GLY GLU TYR ASN LYS ALA SER ASN SEQRES 4 A 120 ASP MET TYR HIS SER ARG ALA LEU GLN VAL VAL ARG ALA SEQRES 5 A 120 ARG LYS GLN ILE VAL ALA GLY VAL ASN TYR PHE LEU ASP SEQRES 6 A 120 VAL GLU LEU GLY ARG THR THR CYS THR LYS THR GLN PRO SEQRES 7 A 120 ASN LEU ASP ASN CYS PRO PHE HIS ASP GLN PRO HIS LEU SEQRES 8 A 120 LYS ARG LYS ALA PHE CYS SER PHE GLN ILE TYR ALA VAL SEQRES 9 A 120 PRO TRP GLN GLY THR MET THR LEU SER LYS SER THR CYS SEQRES 10 A 120 GLN ASP ALA SEQRES 1 B 120 SER SER PRO GLY LYS PRO PRO ARG LEU VAL GLY GLY PRO SEQRES 2 B 120 MET ASP ALA SER VAL GLU GLU GLU GLY VAL ARG ARG ALA SEQRES 3 B 120 LEU ASP PHE ALA VAL GLY GLU TYR ASN LYS ALA SER ASN SEQRES 4 B 120 ASP MET TYR HIS SER ARG ALA LEU GLN VAL VAL ARG ALA SEQRES 5 B 120 ARG LYS GLN ILE VAL ALA GLY VAL ASN TYR PHE LEU ASP SEQRES 6 B 120 VAL GLU LEU GLY ARG THR THR CYS THR LYS THR GLN PRO SEQRES 7 B 120 ASN LEU ASP ASN CYS PRO PHE HIS ASP GLN PRO HIS LEU SEQRES 8 B 120 LYS ARG LYS ALA PHE CYS SER PHE GLN ILE TYR ALA VAL SEQRES 9 B 120 PRO TRP GLN GLY THR MET THR LEU SER LYS SER THR CYS SEQRES 10 B 120 GLN ASP ALA FORMUL 3 HOH *22(H2 O) HELIX 1 1 GLU A 20 ALA A 37 1 18 HELIX 2 2 GLU B 20 SER B 38 1 19 HELIX 3 3 PRO B 105 GLY B 108 5 4 SHEET 1 A 4 MET A 14 ASP A 15 0 SHEET 2 A 4 TYR A 42 THR A 74 -1 O LYS A 54 N MET A 14 SHEET 3 A 4 TYR B 42 THR B 74 -1 O GLU B 67 N LEU A 47 SHEET 4 A 4 VAL B 10 ASP B 15 -1 N MET B 14 O LYS B 54 SHEET 1 B 6 THR A 109 GLN A 118 0 SHEET 2 B 6 LYS A 94 VAL A 104 -1 N PHE A 96 O GLN A 118 SHEET 3 B 6 TYR A 42 THR A 74 -1 N LEU A 68 O ALA A 95 SHEET 4 B 6 TYR B 42 THR B 74 -1 O GLU B 67 N LEU A 47 SHEET 5 B 6 LYS B 94 VAL B 104 -1 O ALA B 95 N LEU B 68 SHEET 6 B 6 THR B 109 ASP B 119 -1 O THR B 116 N SER B 98 SSBOND 1 CYS A 73 CYS A 83 1555 1555 2.05 SSBOND 2 CYS A 97 CYS A 117 1555 1555 2.04 SSBOND 3 CYS B 73 CYS B 83 1555 1555 2.03 SSBOND 4 CYS B 97 CYS B 117 1555 1555 2.04 CRYST1 91.490 91.490 144.450 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010930 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010930 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006923 0.00000